Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
Mian, Michael, Pescosta, Norbert, Badiali, Stefania, Cappelletto, Paola Cristina, Marcheselli, Luigi, Luminari, Stefano, Patriarca, Francesca, Zambello, Renato, Pascarella, Anna, Tagariello, Giuseppe,Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15645
Date:
November, 2018
File:
PDF, 227 KB
english, 2018